Posts Tagged ‘Maarten Titulaer’

Monday March 04th, 2013

Immunotherapy controls 81% of anti-NMDA autoimmune encephalitis

The anti-NMDA autoimmune encephalitis is a disease described in 2005 by a team led by Dr. Josep Dalmau at the University of Pennsylvania (USA). In this disorder the patient’s immune system attacks the NMDA receptors in the brain, which are important for neuronal plasticity. It triggers a wide range of symptoms such as psychosis, behavioral disturbances, memory deficit or loss of consciousness that may be confused with severe psychiatric disorders. The disease affects mainly women, especially young ones. Nowadays Dr. Josep Dalmau heads, thanks to a senior ICREA contract, the Autoimmunity against synaptic antigens IDIBAPS group. In collaboration with colleagues at the University of Pennsylvania, where he keeps collaborating, and other international partners, his team published in Lancet Neurology the keys to successfully treat over 80% of these patients. The first author is Dr. Maarten Titulaer, a Dutch researcher who works at Dr. Dalmau’s IDIBAPS team.

Read the rest of this entry »

Comments Closed